|
⚲
|
| Keyboard |
| Paul Fonteyne | |
|---|---|
| Firm | |
| Address | 39 John F Kennedy Street, 4th Fl Cambridge, MA 02138 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Apnimed Inc | 021-578027 | Director | 25.0 M of 25.0 M |
||
| Allyx Therapeutics Inc | 021-575214 | Director | 3.3 M of 4.0 M |
||
| Triton Therapeutics Inc | 021-561892 | Executive Officer | 36.4 M of 36.4 M |
||
| Apnimed Inc | 021-558476 | Director | 35.0 M of 35.0 M |
||
| Apnimed Inc | 021-544389 | Director | 16.5 M of 16.5 M |
||
| Apnimed Inc | 021-496807 | Director | of 37.5 M |
||
| Allyx Therapeutics Inc | 021-473164 | Director | 2.3 M of 2.3 M |
||
| Gelesis Holdings Inc | 021-456915 | Director | 0.6 M of 50.6 M |
||
| Thyron Pharmaceuticals Inc | 021-444202 | Executive Officer | 0.5 M of 1.0 M |
||
| Revelar Biotherapeutics Inc | 021-434641 | Director | 1.0 M of 1.0 M |
||
| Revelar Biotherapeutics Inc | 021-421689 | Director | 17.5 M of 22.5 M |
||
| Allyx Therapeutics Inc | 021-401376 | Director | 7.6 M of 8.0 M |
||
| Dalcor Pharmaceuticals US LLC | 021-367753 | Director | 3.9 M of 3.9 M |
||